Introduction
The "brain-specific" protein known as S-100 was originally isolated by Moore in 1965 (26) and was characterized by its solubility in 100% ammonium sulfate and by its acidic properties.
It has a molecular weight of 21,000 daltons (7, 15, 27) . (9, 20, 22 ,2 3 , 3 2 ,4 2), tumors of neuroectodermal origin (24,33,38,40,4 1 ,47) 
Immunological Controls
The controls verified the immunospecificity, as indicated in 'In the testicle no S-100 immunoreactivity was detected.
By using an antibody preparation against crude S-bOO protein ( Figure  1A) the following staining was observed:
In the rat submandibular gland, intensive fluorescence was seen in the striated ducts.
A weaker immunofluorescence was detected in the granular ducts, localized to membranes and/or cytoplasm ( Figure  1A) . Secretory granules were negative with respect to the S-1 00 protein and pretreatment of the sections with trypsin for 40 mm (2 1 ) resulted in the same distribution of immunoreactivity as without pretreatment.
A few brightly stained cells that were devoid of granules were interspersed among the granular duct cells (see also Figure  2A ). The fluorescence decreased and varied from one cell to another in the interlobar and main excretory ducts ( Figure  2D ). In the intercalated duct of the submandibular gland a few S-100-positive cells were interspersed among the negatively stained cells ( Figures  1C,  D) . Such S-100-positive cells were more frequently seen near the lobes in the distal part of the gland.
The sublingual gland ducts displayed a uniformly distributed, very intense immunoreactivity for the S-100 protein.
The basal striation could readily be seen in the striated ducts. The intercalated duct cells of the sublingual gland were weakly positive.
The transition in fluorescence between the intercalated and striated ducts was also pronounced since no granular ducts were present ( Figure   1E ). In Figure  1B) . Consistent findings were obtained if anti-S-lOOa non-/3 was used ( Figure  2B,E) . The exclusive localization of the f3-like subunit in these cells was confirmed by the use of affinity-purified antibodies against the 3 subunit (anti-S-100f3) ( Figure  2C,F) . Identical results were seen if anti-S-100f3 was prepared either from anti-S-lOOa or from anti-S-lOOb by affinity chromatography. However, striated and excretory duct cells ofall three major salivary glands and granular duct cells of the submandibular gland remained positive with anti-crude 5-100 abs b ( Figure  1B) and affinity-purified anti S-lOOa non-a ( Figure  2B ,E). Similar results were obtained in the intercalated duct cells of the sublingual gland ( Figure  1E ). In contrast, astrocytes and ependymal cells could be visualized with antibody preparations directed against a, as well as against the /3 subunit ( #{176}Subunit specific antibodies.
Crossed Immunoelectrophoresis
To assess the identity of the S-100 cross-reacting antigens in salivary glands, supernatants of homogenates of rat brain and submandibular gland were compared by crossed immunoelectrophoresis against anti-crude S-100 serum ( Figure  5 A-C).
Fusion of precipitation lines was demonstrated in tandem electrophoresis ( Figure  SC) . Furthermore, the electrophoretic mobility of salivary gland S-l00 is almost identical to that of brain ( Figure  5A,B) in duct epithelia (four out of ten intralobular ducts ( + )) as well as in acinar cells (short arrows).
Intercalated duct (long arrow). Compare with Figure 1A -D.
In frozen sections, immunological controls showed a somewhat brighter staining of duct epithelia than did paraffin-embedded tissue, not illustrated (see Figure 2C for comparison). Bar = 50 pm. bility was similar.
No spurs were demonstrated. However, the appearance of the precipitation archs differed, which apart from being due to a 1 5-fold larger sample volume for the submandibular gland extract could be due to differences in the state of the antigen (polymer forms). The immunoreactive substances in the salivary glands will therefore be referred to as 5-100. Secondly, immunocytochemical specificity was ascertained for the 5-100 subunits (a non-3 and /3), since a complementary immunocytochemical staining was obtained for crude S-100, S-lOOa non-a, and 5-100/3 ( Figure  2A-F ( 19, 37, 45, 49, 50) . "Biologically active peptides" ( 1 ) are, with a few exceptions, localized to the 
